Successful Early Rescue with Isatuximab Plus Carfilzomib-Dexamethasone (ISA-KD) in Daratumumab-Refractory Newly Diagnosed Multiple Myeloma (NDMM) Patients with “No Washout Period”: A Real-World Clinical Experience in A Case Series and Literature Review. acmcr. 2026;10(1):1-5. Accessed September 11, 2026. https://fortunejournals.org/ojs/index.php/acmcr/article/view/23020